Successful Treatment of Subungual Fibromas of Tuberous Sclerosis With Topical Rapamycin

JAMA Dermatology - United States
doi 10.1001/jamadermatol.2014.87
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Retraction: Mammalian Target of Rapamycin Inhibitors for Treatment in Tuberous Sclerosis

Korean Journal of Pediatrics
Child HealthPediatricsPerinatology
2013English

Topical Rapamycin for Angiofibromas in Patients With Tuberous Sclerosis: How Does It Work in Clinical Practice?

Plastic and Aesthetic Research
2016English

Efficacy of Rapamycin in Tuberous Sclerosis–Associated Hypopigmented Macules

JAMA Dermatology
DermatologyMedicine
2015English

Rapamycin Prevents Epilepsy in a Mouse Model of Tuberous Sclerosis Complex

Annals of Neurology
Neurology
2008English

Topical Rapamycin for Facial Angiofibromas in a Child With Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-Up

Dermatology and Therapy
Dermatology
2017English

Successful Treatment of Bowen’s Disease With Topical Maxacalcitol

Acta Dermato-Venereologica
DermatologyMedicine
2012English

Successful Treatment of Recalcitrant Condyloma With Topical Cidofovir

Sexually Transmitted Infections
DermatologyInfectious Diseases
2000English

Long-Term Treatment of Epilepsy With Everolimus in Tuberous Sclerosis

Neurology
Neurology
2016English

PND48 Real World Treatment Profile of Patients With Tuberous Sclerosis Complex

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy